 |
인쇄하기
취소
|
Hanmi, MSD to cooperate over Amosartan
Hanmi Pharmaceutical and the US based Merck & Co. signed their second contract to sell Hanmi's incrementally modified hypertensive amlodipine product Amosartan in 30 countries, under Merck's brand Cozzar XQ.
The company earlier signed a contract with Merck for overseas licensing out agreement containing the content of transferring license at six Asia Pacific nations to Merck.
Under the ag...
The company earlier signed a contract with Merck for overseas licensing out agreement containing the content of transferring license at six Asia Pacific nations to Merck.
Under the ag...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.